Product Images Fibryga

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 22 images provide visual information about the product associated with Fibryga NDC 68982-350 by Octapharma Usa Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image File - img0001

This text provides a formula for calculating the dose of a medication based on the difference between the target fibrinogen level and the measured fibrinogen level in the blood. The formula calculates the dose in milligrams per kilogram of body weight using a factor of 18.*

Image File - img0002

This text provides a formula for calculating the dose of a medication in milligrams per kilogram of body weight based on the difference between the target fibrinogen level and the measured fibrinogen level. The formula multiplies this difference by 1.4 mg/dL per mg/kg body weight to determine the appropriate dosage.*

Image File - img0003

Image File - img0004

Image File - img0005

Image File - img0006

Image File - img0007

This text mentions an empty diluent and a reconstituted product called FIBRYGA. It appears to refer to a process involving dilution and reconstitution of a substance. The text also includes a reference to a figure (Fig. 5) which may provide further details or visuals related to the process.*

Image File - img0008

Image File - img0009

This text provides incomplete information. Without further context, it is not possible to provide a useful description. It appears to mention a product called "FIBRYGA" and could possibly refer to a reconstituted bottle of this product. Additional details or clarity are needed to determine the exact meaning of the text.*

Image File - img0010

This text is not readable.*

Image File - img0011

This text appears to be a table showing the production step and the corresponding virus reduction factors for different types of viruses including enveloped and non-enveloped viruses. The data includes information about specific viruses such as HIV, PRV, BVDV, HAV, and PPV, as well as the methods used for virus reduction such as S/D treatment and Nanofiltration. The table also indicates cumulative virus reduction factors.*

Image File - img0012

This text provides a comparison of pharmacokinetic parameters among different age groups (adult and adolescent patients, pediatric patients aged 6 to <12 years, and pediatric patients under 6 years of age). The parameters evaluated include half-life, Cmax (maximum concentration), AUC (area under the curve), AUCsemm for a dose of 70 mg/kg, incremental IVR, clearance, mean residence time, and volume of distribution at steady state. The data includes mean values, standard deviations, and ranges for each parameter, helping to understand how the drug behaves in different populations.*

Image File - img0013

This text is not available.*

Image File - img0014

Image File - img0015

Image File - img0016

This is a reference to a diluent for FIBRYGA in a bottle, as shown in Figure 4.*

Image File - img0017

This is a reference to using an empty diluent to reconstitute a FIBRYGA bottle. Figure 5 might provide visual instructions or guidance related to this process.*

Image File - img0018

Image File - img0019

This is not-available.*

Image File - img0020

This is not-available*

Image File - img0021

This is a description for a medical product called FIBRYGA, which is a lyophilized powder for reconstitution used for intravenous administration to treat fibrinogen deficiency. It is advised to store the product protected from light and not freeze it. The product information includes the lot number, expiration date, NDC number, and instructions on storage and administration. For more details on dosage and administration, it is recommended to refer to the package insert or contact the manufacturer at 866-766-4860.*

Image File - img0022

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents